Original Article | Published:

Survey and evidence based review of probiotics used in very low birth weight preterm infants within the United States

Journal of Perinatology volume 36, pages 11061111 (2016) | Download Citation

  • A Corrigendum to this article was published on 04 January 2017

Abstract

Objective:

Data from multiple clinical trials, mostly conducted outside the US, indicate that probiotic prophylaxis is an effective intervention for prevention of necrotizing enterocolitis (NEC) in preterm infants. Probiotics are routinely used in many countries. However, in the US, probiotic use in preterm infants is limited (6.7% of very low birth weight (VLBW) infants in the US were exposed to probiotics in 2014, Vermont Oxford Network (VON)). Probiotic products are often considered in ‘generic’ terms, but considerable variation exists between commercially available probiotics in terms of their quantity and quality. The study objectives were to identify the probiotic products used in VLBW infants within the US, and to determine whether their use was supported by reliable evidence.

Study Design:

A phone survey of all neonatal intensive care units (NICU) participating in VON within the US was conducted between May and September 2015 to identify NICUs that are using probiotics in VLBW infants. Data was collected regarding specific probiotic brands, timing, dose and duration of probiotic use. An evidence based literature search, limited to randomized controlled trials in VLBW infants, was conducted to determine whether the use of identified probiotics were supported by reliable evidence.

Results:

There was a 70.3% (500/711) response rate to the phone survey. During the survey period, 14.0% of NICUs were using probiotics in VLBW infants (70/500). Probiotics were routinely given to all VLBW infants in 8.8% (44/500) NICUs, while it was given in selected VLBW infants in 5.2% (26/500) of NICUs. The common indications for selective use of probiotics were feeding intolerance and antibiotic use. Sixteen commercial probiotics products were identified through the phone survey. Probiotic products most commonly used were Culturelle (27.1%), Biogaia (14.3%), Gerber Soothe (14.3%) and Florababy (8.6%). The literature search identified evidence that evaluated 4/16 probiotic products identified (Culturelle, Align, Biogaia and ABC Dophilus). Only ABC Dophilus was reported to have a protective effect against NEC, but is used sparingly in US NICUs (2.9%).

Conclusions:

The probiotics use in VLBW infants within the US is increasing, but is still limited. There was no evidence for safety or efficacy of 90% of the probiotics currently used in US NICUs, and therefore, caution is warranted.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , , , , , et al. Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg 2009; 44(6): 1072–1075;discussion 5–6.

  2. 2.

    , , , , , et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 2015; 314(10): 1039–1051.

  3. 3.

    , , , , , . A meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Braz J Med Biol Res 2014; 47(9): 804–810.

  4. 4.

    , . Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2014; 4: CD005496.

  5. 5.

    , . Probiotic administration can prevent necrotizing enterocolitis in preterm infants: a meta-analysis. J Pediatr Surg 2015; 50(8): 1405–1412.

  6. 6.

    , , . Probiotics in neonatal intensive care - back to the future. Aust N Z J Obstet Gynaecol 2015; 55(3): 210–217.

  7. 7.

    . Probiotics to prevent necrotizing enterocolitis: too cheap and easy? Paediatr Child Health 2014; 19(7): 351–352.

  8. 8.

    Vermont Oxford Network. Database of very low birth weight infants. 2013-2014. Nightingale Internet Reporting System. Available at: . Accessed on: December 2015.

  9. 9.

    , , , . Case series of Bifidobacterium longum bacteremia in three preterm infants on probiotic therapy. Neonatology 2015; 107(1): 56–59.

  10. 10.

    , , , , . Bifidobacterium septicaemia in an extremely low-birthweight infant under probiotic therapy. Arch Dis Child Fetal Neonatal Ed 2012; 97(3): F217–F218.

  11. 11.

    Infectious Diseases Pathology Branch, Infectious Diseases Pathology Branch, Infectious Diseases Pathology Branch, Infectious Diseases Pathology Branch, Infectious Diseases Pathology Branch, Infectious Diseases Pathology Branch, et alInfectious Diseases Pathology Branch. Notes from the field: fatal gastrointestinal mucormycosis in a premature infant associated with a contaminated dietary supplement—Connecticut, 2014. MWMR 2015; 64: 155–156.

  12. 12.

    , , , , Probiotics in Preterm Infants Study Collaborative Group. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet 2016; 387(10019): 649–660.

  13. 13.

    . Not all probiotic strains prevent necrotising enterocolitis in premature infants. Lancet 2016; 387(10019): 624–625.

  14. 14.

    , . The human neonatal gut microbiome: a brief review. Front Pediatr 2015; 3: 17.

  15. 15.

    , , , , . Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002; 82(2): 103–108.

  16. 16.

    , , , , , et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis 2006; 42(12): 1735–1742.

  17. 17.

    , , , , , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Hum Dev 2014; 90(Suppl 1): S60–S65.

  18. 18.

    , , , , , et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005; 147(2): 192–196.

  19. 19.

    , , , , , et al. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics 2013; 132(6): 1055–1062.

  20. 20.

    , , , , , et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005; 115(1): 1–4.

  21. 21.

    , , , , , et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 2008; 122(4): 693–700.

  22. 22.

    , , . Effect of oral probiotics supplementation in the prevention of necrotizing enterocolitis among very low birth weight preterm infants. J Med Assoc Thai 2014; 97(Suppl 6): S20–S25.

  23. 23.

    , , , , , et al. Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2009; 89(6): 1828–1835.

  24. 24.

    , , , , , . Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J Trop Pediatr 2009; 55(2): 128–131.

  25. 25.

    , , , , . Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial. Neonatology 2010; 98(2): 156–163.

  26. 26.

    , , , . Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial. Am J Clin Nutr 2011; 93(1): 81–86.

  27. 27.

    , , , , , . Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial. Eur J Clin Nutr 2011; 65(4): 434–439.

  28. 28.

    , , , , , et al. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics 2012; 130(5): e1113–e1120.

  29. 29.

    , , , , , et al. Lactobacillus reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2014; 99(2): F110–F115.

  30. 30.

    , , , , , et al. Probiotics-supplemented feeding in extremely low-birth-weight infants. J Perinatol 2012; 32(4): 253–259.

  31. 31.

    , , , . Saccharomyces boulardii for prevention of necrotizing enterocolitis in preterm infants: a randomized, controlled study. Acta Paediatr 2013; 102(12): e560–e565.

  32. 32.

    , , , , . Efficacy of Saccharomyces boulardii on necrotizing enterocolitis or sepsis in very low birth weight infants: a randomised controlled trial. Early Hum Dev 2013; 89(12): 1033–1036.

  33. 33.

    , , , , , et al. Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed 2013; 98(1): F5–F9.

  34. 34.

    , , , , , . Bifidobacterium and enteral feeding in preterm infants: cluster-randomized trial. Pediatr Int 2014; 56(5): 714–719.

  35. 35.

    , , , , , et al. The propre-save study: effects of probiotics and prebiotics alone or combined on necrotizing enterocolitis in very low birth weight infants. J Pediatr 2015; 166(3): 545–51.e1.

  36. 36.

    , , , , . Influence of a combination of probiotics on bacterial infections in very low birthweight newborns. Wien Klin Wochenschr 2015; 127(Suppl 5): 210–215.

  37. 37.

    , . Commensal and probiotic bacteria may prevent NEC by maturing intestinal host defenses. Pathophysiology 2014; 21(1): 47–54.

  38. 38.

    . Probiotics and prebiotics in neonatal necrotizing enterocolitis: new opportunities for translational research. Pathophysiology 2014; 21(1): 35–46.

  39. 39.

    , , , , . The time for a confirmative necrotizing enterocolitis probiotics prevention trial in the extremely low birth weight infant in North America is now!. J Pediatr 2014; 165(2): 389–394.

  40. 40.

    , , , . Inflammatory signals that regulate intestinal epithelial renewal, differentiation, migration and cell death: Implications for necrotizing enterocolitis. Pathophysiology 2014; 21(1): 67–80.

  41. 41.

    , , , , , et al. Conditions of bifidobacterial colonization in preterm infants: a prospective analysis. J Pediatr Gastroenterol Nutr 2007; 44(5): 577–582.

  42. 42.

    , , , , , et al. Bifidobacterium longum bacteremia in preterm infants receiving probiotics. Clin Infect Dis 2015; 60(6): 924–927.

  43. 43.

    , , , , . Lactobacillus sepsis following a laparotomy in a preterm infant: a note of caution. Neonatology 2016; 109(3): 186–189.

  44. 44.

    , , , , , . Microbiological and genetic analysis of probiotic products licensed for medicinal purposes. Med Sci Monit 2004; 10(9): BR346–BR350.

  45. 45.

    , , , , . Culture-dependent and culture-independent qualitative analysis of probiotic products claimed to contain bifidobacteria. Int J Food Microbiol 2005; 102(2): 221–230.

  46. 46.

    , , , , . Microbiological evaluation of commercial probiotic products available in the USA in 2009. J Chemother 2010; 22(6): 373–377.

Download references

Author information

Affiliations

  1. Division of Neonatology, Department of Pediatrics, Rainbow Babies & Children's Hospital, University Hospitals, Case Western Reserve University, Cleveland, OH, USA

    • S Viswanathan
    • , C Lau
    • , H Akbari
    •  & M C Walsh
  2. Division of Pediatric Infectious Diseases, Department of Pediatrics, Rainbow Babies & Children's Hospital, University Hospitals, Case Western Reserve University, Cleveland, OH, USA

    • C Hoyen

Authors

  1. Search for S Viswanathan in:

  2. Search for C Lau in:

  3. Search for H Akbari in:

  4. Search for C Hoyen in:

  5. Search for M C Walsh in:

Competing interests

The authors declare no conflict of interest.

Corresponding author

Correspondence to S Viswanathan.

About this article

Publication history

Received

Revised

Accepted

Published

DOI

https://doi.org/10.1038/jp.2016.144